Glycogen storage disease type V is a rare inherited condition that affects how muscles use stored energy during physical activity. While there is no cure, understanding treatment approaches—from dietary strategies to supervised exercise programs—can help people with this condition manage symptoms and maintain an active life.

Understanding Treatment Goals for Muscle Energy Disorders

When someone lives with glycogen storage disease type V, also called McArdle disease, their muscles cannot break down a stored form of sugar called glycogen into usable energy. This creates unique challenges during physical activity, but it doesn’t mean giving up on an active lifestyle. The main goals of treatment focus on helping people exercise safely, preventing serious complications like muscle breakdown, and improving overall quality of life.^[1]

Treatment strategies depend heavily on individual symptoms and how severely the condition affects daily activities. Some people experience only mild fatigue and poor stamina, while others face frequent muscle pain and cramps during even light physical activity. The approach to managing this condition has evolved significantly over the years, moving from simple avoidance of exercise to carefully structured activity programs that actually help improve muscle function.^[2]

Currently, medical professionals use a combination of lifestyle modifications, dietary adjustments, and exercise training recommended by clinical guidelines to help patients manage their symptoms. While researchers continue to explore new therapies in clinical trials, the standard treatments available today focus on practical strategies that people can incorporate into their daily routines. These approaches aim to prevent the muscle damage that can occur with intense or prolonged exercise, while still allowing individuals to stay physically active and maintain their independence.^[4]

Standard Treatment Approaches

Dietary Management and Nutritional Support

One of the most important standard treatments involves strategic eating patterns designed to provide muscles with alternative energy sources. Since people with McArdle disease cannot effectively use the glycogen stored in their muscles, providing readily available glucose from the diet becomes crucial. Healthcare providers often recommend consuming simple carbohydrates—easily digestible sugars—before physical activity to give muscles immediate fuel they can use without needing to break down glycogen.^[4]

Sports drinks containing simple carbohydrates have shown particular benefit when consumed before exercise. These beverages provide glucose that muscles can use directly, bypassing the blocked metabolic pathway. This approach not only improves exercise tolerance but may also protect against the dangerous muscle breakdown that can occur during strenuous activity. The timing of carbohydrate intake matters significantly—consuming these sugars shortly before beginning physical activity provides the most benefit.^[4]

Adequate protein intake is another dietary consideration. Healthcare providers may recommend ensuring sufficient protein in the diet to support overall muscle health and maintenance. Some individuals find that eating protein-rich foods helps them maintain better stamina throughout the day, although the mechanisms behind this benefit are not fully understood.^[5]

Supervised Exercise Programs

Rather than avoiding physical activity entirely, current treatment guidelines emphasize carefully structured exercise training. Moderate-intensity aerobic exercise, such as walking, brisk walking, or bicycling, has become a cornerstone of managing McArdle disease. This might seem counterintuitive for a condition that causes exercise intolerance, but regular, appropriate physical activity actually helps improve muscle function over time.^[4]

The key to safe exercise lies in understanding the “second wind” phenomenon that many people with this condition experience. During the first few minutes of activity, muscles struggle because they cannot access their glycogen stores, leading to pain, fatigue, and cramping. However, if the person rests briefly and allows these symptoms to subside, they can often resume activity with much less discomfort. This second wind occurs because the body shifts to using alternative fuel sources, particularly fat and glucose from the bloodstream.^[1]

Healthcare providers recommend starting exercise slowly with a gentle warm-up period. This gradual approach allows the body’s alternative energy systems to activate before demanding too much from the muscles. The duration and intensity of exercise should be carefully monitored and gradually increased as tolerance improves. Regular aerobic training can increase cardiorespiratory fitness—the ability of the heart and lungs to supply oxygen to working muscles—and enhance the muscles’ ability to use oxygen efficiently, a measure called muscle oxidative capacity.^[4]

Certain types of exercise should be avoided entirely. Isometric exercises, which involve muscle contraction without movement—such as lifting very heavy objects, squatting, or standing on tiptoes—pose particular risk for muscle damage. Similarly, maximal aerobic exercise that pushes the body to its absolute limits can trigger the dangerous muscle breakdown that leads to kidney complications. The goal is to find a sustainable level of activity that provides health benefits without crossing into dangerous territory.^[4]

Awareness and Preventive Strategies

Education about physical limitations forms an essential part of treatment. People with McArdle disease need to understand their body’s signals and recognize when to stop or modify an activity. Being aware of what types of movements and activities trigger symptoms allows individuals to make informed decisions about their daily activities and exercise routines.^[5]

Before undergoing any surgical procedures, individuals should discuss their condition with their healthcare providers. Certain types of anesthesia and the stress of surgery can potentially affect muscle function, so medical teams need to be aware of the diagnosis to plan appropriately.^[5]

Medical Monitoring and Surveillance

Regular follow-up with healthcare providers is recommended for all individuals with McArdle disease. Annual routine physical examinations help monitor overall health status and muscle function. During these visits, healthcare providers review dietary habits and exercise patterns to ensure the treatment plan remains appropriate. Blood tests may be performed to check creatine kinase levels, an enzyme released when muscle damage occurs, which helps assess whether the current activity level is safe.^[4]

Limitations of Current Standard Treatments

Despite these management strategies, standard treatment approaches have significant limitations. Multiple clinical trials have tested various medications and nutritional supplements hoping to improve muscle function in McArdle disease, but most have shown disappointing results. Studies have evaluated substances including D-ribose, glucagon, verapamil, vitamin B6, branched-chain amino acids, dantrolene sodium, and high-dose creatine, but none demonstrated clear benefit for improving exercise performance.^[7]

There is currently no specific medication that can replace the missing enzyme or directly address the underlying metabolic problem. This means that treatment remains focused on symptomatic management—helping people work around their metabolic limitations rather than correcting them. The lack of disease-modifying therapies represents a significant unmet need in the treatment of this condition.^[7]

Treatment Approaches Being Tested in Clinical Trials

The Challenge of Developing New Therapies

Researchers have been actively searching for treatments that could more directly address the enzyme deficiency at the heart of McArdle disease. Unlike some other glycogen storage diseases where enzyme replacement therapy has proven successful, developing such treatments for McArdle disease faces unique challenges. The missing enzyme, myophosphorylase, needs to be present specifically within muscle cells throughout the body, making delivery particularly complex.^[2]

Clinical trials for rare diseases like McArdle disease often face difficulties recruiting enough participants to demonstrate whether a treatment works. The disease affects an estimated 1 in 100,000 to 1 in 200,000 people, which means that even large medical centers may only see a handful of patients. This rarity makes it challenging to conduct the large-scale studies typically needed to prove that a new treatment is both safe and effective.^[1]

Gene Therapy Research

One of the most promising areas of research involves gene therapy approaches aimed at correcting the underlying genetic defect. Scientists are exploring whether they can deliver a working copy of the PYGM gene—the gene responsible for making myophosphorylase—directly to muscle cells. This approach has shown success in treating other types of glycogen storage disease, raising hope that similar strategies might work for McArdle disease.^[10]

These experimental gene therapies typically use specially modified viruses called adeno-associated virus vectors to carry the correct genetic instructions into cells. The virus has been engineered to be safe—it cannot cause infection or disease—but retains its natural ability to enter cells and deliver genetic material. Once inside muscle cells, the new gene could potentially allow those cells to produce the missing enzyme, restoring the ability to break down glycogen.^[10]

Animal studies testing gene therapy for McArdle disease have shown encouraging preliminary results, with treated mice demonstrating improved muscle enzyme activity and better tolerance of fasting periods. However, these experimental approaches remain in early research phases and have not yet been tested in human clinical trials. Significant work remains to determine the optimal way to deliver genes to enough muscle cells throughout the body to make a meaningful clinical difference.^[10]

Novel Nutritional and Pharmacological Approaches

Researchers continue to investigate various substances that might improve muscle energy metabolism through different pathways. One area of investigation involves modified forms of cornstarch. While primarily used for other types of glycogen storage disease affecting the liver, scientists have explored whether a specially formulated cornstarch called WMHM20, which has different physical properties than regular cornstarch, might provide benefit. This modified cornstarch is designed to release glucose more slowly and steadily, potentially providing muscles with a more consistent fuel supply.^[10]

Clinical trials have examined this modified cornstarch in people with different types of glycogen storage disease. In conditions affecting the liver, such as types I and III, this approach showed some promise for better controlling blood glucose levels and extending the time between meals. However, the benefit for McArdle disease, which primarily affects muscles rather than the liver, remains less clear and requires further study.^[10]

Various other pharmacological agents have entered clinical testing based on theories about how they might improve muscle metabolism. These trials typically follow a structured progression through different phases. Phase I trials focus primarily on safety—determining whether the treatment causes any harmful side effects and what dose is appropriate. Phase II trials then test whether the treatment actually works, measuring effects on exercise capacity, muscle strength, or other relevant outcomes. Phase III trials compare the new treatment directly against standard care or placebo to definitively establish its value.^[7]

Understanding Clinical Trial Results

A comprehensive review of randomized controlled trials testing various treatments for McArdle disease found limited evidence of benefit from most interventions tested. This systematic review, which examined studies involving a total of 85 participants across multiple trials, concluded that substances including D-ribose, glucagon, verapamil, vitamin B6, branched-chain amino acids, dantrolene sodium, and high-dose creatine did not show clear improvements in exercise performance or muscle symptoms.^[7]

The small number of participants in each individual trial represents a significant limitation. The largest treatment trial included only 19 people, while the smallest involved just a single participant. These small sample sizes make it difficult to detect real treatment effects and to distinguish genuine improvements from random variation. Nevertheless, the trials were conducted according to rigorous scientific standards, using randomized, controlled designs that help minimize bias.^[7]

Some studies reported minimal subjective benefit—meaning that participants felt somewhat better—with certain interventions, but these improvements were not accompanied by measurable changes in exercise capacity or other objective measures. This discrepancy highlights the complexity of evaluating treatments for conditions where symptoms can vary significantly from day to day and person to person.^[7]

Ongoing Research Directions

The scientific community continues to search for novel therapeutic approaches. Research teams are investigating ways to enhance the body’s ability to use alternative fuel sources during exercise, since the “second wind” phenomenon demonstrates that people with McArdle disease can exercise reasonably well once their bodies shift to using fat and blood glucose instead of muscle glycogen. Understanding and potentially enhancing this metabolic shift could lead to new treatment strategies.^[2]

Other researchers are exploring whether modifying specific metabolic pathways within muscle cells might compensate for the missing enzyme. These approaches look for alternative routes through which muscles might generate energy, essentially finding workarounds for the blocked pathway. While still in very early experimental stages, such strategies could eventually lead to new pharmacological treatments.^[10]

Most Common Treatment Methods

• Dietary Modifications
  • Pre-exercise consumption of sports drinks containing simple carbohydrates to provide readily available glucose to muscles
  • Adequate protein intake to support overall muscle health and maintenance
  • Strategic timing of carbohydrate consumption before physical activity
• Structured Exercise Training
  • Moderate-intensity aerobic exercise including walking, brisk walking, or bicycling
  • Gentle warm-up periods before exercise to allow alternative energy systems to activate
  • Gradual progression of exercise duration and intensity based on individual tolerance
  • Avoiding isometric exercises and maximal aerobic exercise that increase risk of muscle damage
  • Utilizing the “second wind” phenomenon by resting briefly when symptoms appear
• Lifestyle Adjustments
  • Education about physical limitations and recognizing warning signs of excessive muscle stress
  • Awareness of activities and movements that trigger symptoms
  • Planning daily activities to balance energy expenditure
• Medical Monitoring
  • Annual routine physical examinations to monitor overall health and muscle function
  • Review of dietary habits and exercise patterns
  • Blood tests to check creatine kinase levels as indicators of muscle damage